Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Brie Chun"'
Autor:
David B. Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L. Redmond, Maritza Martel, Zhaoyu Sun, Mary B. Campbell, Alison Conlin, Anupama Acheson, Reva Basho, Philomena McAndrew, Mary El-Masry, Dorothy Park, Laura Bennetts, Robert S. Seitz, Tyler J. Nielsen, Kimberly McGregor, Venkatesh Rajamanickam, Brady Bernard, Walter J. Urba, Heather L. McArthur
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Chemoimmunotherapy with anti-programmed cell death 1/ligand 1 and cytotoxic chemotherapy is a promising therapeutic modality for women with triple-negative breast cancer, but questions remain regarding optimal chemotherapy backbone and bioma
Externí odkaz:
https://doaj.org/article/0206d7fb11584f5ab468ac8a9e5bed64
Autor:
Duygu Altinok Dindar, Brie Chun, Amy Palma, John Cheney, Madeline Krieger, Kristin Kasschau, Keaton Stagaman, Zahi I. Mitri, Shaun M. Goodyear, Jackilen Shannon, Lisa Karstens, Thomas Sharpton, Zhenzhen Zhang
Publikováno v:
Nutrients, Vol 15, Iss 21, p 4628 (2023)
Breast cancer (BCa) has many well-known risk factors, including age, genetics, lifestyle, and diet; however, the influence of the gut microbiome on BCa remains an emerging area of investigation. This study explores the connection between the gut micr
Externí odkaz:
https://doaj.org/article/d29d323960f44a70894f7d1ec1711186
Autor:
Katherine Sanchez, Isaac Kim, Brie Chun, Joanna Pucilowska, William L. Redmond, Walter J. Urba, Maritza Martel, Yaping Wu, Mary Campbell, Zhaoyu Sun, Gary Grunkemeier, Shu Ching Chang, Brady Bernard, David B. Page
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-15 (2021)
Abstract Background The H&E stromal tumor-infiltrating lymphocyte (sTIL) score and programmed death ligand 1 (PD-L1) SP142 immunohistochemistry assay are prognostic and predictive in early-stage breast cancer, but are operator-dependent and may have
Externí odkaz:
https://doaj.org/article/15073214387d495795317299a2e6cda4
Autor:
William L Redmond, David B Page, Walter J Urba, Heather L McArthur, Yoshinobu Koguchi, Valerie Conrad, Nathan Polaske, ShuChing Chang, Venkatesh Rajamanickam, Brady Bernard, Isaac Kim, Brie Chun, Joanna Pucilowska, Benjamin Nikitin, Mark Schmidt, Paul A Fields, Alison K Conlin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/3acb56bb40424933b53c4935731d3195
Autor:
Heather McArthur, William Redmond, Walter Urba, Yoshinobu Koguchi, Valerie Conrad, David Page, Nathan Polaske, Alison Conlin, Venkatesh Rajamanickam, Brady Bernard, Isaac Kim, Brie Chun, Joanna Pucilowska, Shu Ching Chang, Benjamin Nikitin, Paul Fields, Mark Schmidt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/cce097551a684be5ba030ca746e785a7
Autor:
William Redmond, Walter Urba, Yoshinobu Koguchi, David Page, Maritza Martel, Staci Mellinger, Ayca Gucalp, Zhaoyu Sun, Yaping Wu, Brie Chun, Krystle Collins, Nicole Moxon, Tiffany Traina
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/5f24ba7a0dff4a68a1d7a1bc2ae0e4f3
Autor:
Isaac Kim, Venkatesh Rajamanickam, Brady Bernard, Brie Chun, Yaping Wu, Maritza Martel, Zhaoyu Sun, William L. Redmond, Katherine Sanchez, Reva Basho, Heather McArthur, David B. Page
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Metaplastic breast cancer is a rare and often chemo-refractory subtype of breast cancer with poor prognosis and limited treatment options. Recent studies have reported overexpression of programmed death ligand 1 (PD-L1) in metaplastic breast cancers,
Externí odkaz:
https://doaj.org/article/26bf8883094c4f2cb8a95cd6a86fca34
Autor:
Brie Chun, Shaun Goodyear, Travis Rice-Stitt, Lisa Karstens, Erin Dahl, Allen Li, Evthokia Hobbs, Mitri Zahi
Publikováno v:
Cancer Research. 83:P1-04
Background: Greater gut microbiome diversity is observed in patients with a clinical response to immune checkpoint inhibitor (ICI) therapy in solid tumors and in preclinical models targeting the gut microbiome is a promising strategy to improve ICI e
Autor:
Malinda T West, Shaun M Goodyear, Evthokia A Hobbs, Andy Kaempf, Thomas Kartika, Jessica Ribkoff, Brie Chun, Zahi I Mitri
Publikováno v:
The Oncologist.
BackgroundCyclin-dependent kinase 4/6 inhibitors (CDKi) have changed the landscape for treatment of patients with hormone receptor positive, human epidermal growth factor receptor 2-negative (HR+/HER−) metastatic breast cancer (MBC). However, next-
Autor:
David B Page, Krystle L Collins, Brie Chun, Zhaoyu Sun, William L Redmond, Maritza Martel, Yaping Wu, Nicole Moxon, Staci L Mellinger, Walter J Urba, Tiffany A Traina, Ayca Gucalp
Publikováno v:
Cancer Research. 82:OT1-18
Background: The addition of anti-programmed death 1/ligand 1 (anti-PD-1/L1) improves progression-free survival when combined with chemotherapy in PD-L1-positive triple-negative MBC. However, novel combination therapies are needed to improve efficacy